UBS Group’s Praxair Inc PX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-236,100
Closed -$37.9M 8649
2018
Q3
$37.9M Buy
236,100
+220,000
+1,366% +$35.3M 0.02% 819
2018
Q2
$2.55M Buy
+16,100
New +$2.49M ﹤0.01% 2946
2018
Q1
Sell
-10,000
Closed -$1.55M 8434
2017
Q4
$1.55M Sell
10,000
-4,800
-32% -$712K ﹤0.01% 3415
2017
Q3
$2.07M Buy
14,800
+14,500
+4,833% +$1.93M ﹤0.01% 3100
2017
Q2
$40K Sell
300
-17,700
-98% -$2.27M ﹤0.01% 5826
2017
Q1
$2.13M Buy
+18,000
New +$2.12M ﹤0.01% 2889
2015
Q3
Sell
-24,300
Closed -$2.9M 8825
2015
Q2
$2.9M Buy
24,300
+23,200
+2,109% +$2.83M ﹤0.01% 2619
2015
Q1
$133K Sell
1,100
-8,900
-89% -$1.11M ﹤0.01% 5201
2014
Q4
$1.3M Buy
+10,000
New +$1.27M ﹤0.01% 3355

Other funds holding PX

UBS Group's PX Position: Q4 2018 in Review

UBS Group sold out of Praxair Inc (PX) in Q4 2018, closing a stake of 3,287,226 shares — an estimated $528M sold.

UBS Group first reported a position in PX in Q4 2014 and held it in 16 quarters. The position peaked at $628M in Q4 2017. 6 funds tracked by Wall St. Rank hold PX as of Q4 2018.

  • UBS Group reported no remaining Praxair Inc position as of Q4 2018 after selling out during the quarter.
  • UBS Group sold 3,287,226 Praxair Inc shares in Q4 2018, an estimated $528M.
  • UBS Group first reported a position in Praxair Inc in Q4 2014 and held it in 16 quarters.
  • UBS Group's Praxair Inc position peaked at $628M in Q4 2017.
  • 6 funds tracked by Wall St. Rank held Praxair Inc as of Q4 2018.

Based on UBS Group's 13F filing for Q4 2018, filed 14 Feb 2019.